Vitro, S.A.B. de C.V.
VITOF
$0.66
-$0.01-1.49%
OTC PK
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -2.27% | -86.99% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.27% | -86.99% | |||
| Cost of Revenue | -0.75% | -91.13% | |||
| Gross Profit | -3.83% | -75.02% | |||
| SG&A Expenses | -5.02% | -74.40% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -357.63% | 281.38% | |||
| Total Operating Expenses | -16.95% | -87.19% | |||
| Operating Income | 152.90% | -84.31% | |||
| Income Before Tax | 1,052.53% | -108.58% | |||
| Income Tax Expenses | 1,071.40% | -19.90% | |||
| Earnings from Continuing Operations | 1,043.10% | -105.59% | |||
| Earnings from Discontinued Operations | 333.97% | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 531.00% | -61.06% | |||
| EBIT | 152.90% | -84.31% | |||
| EBITDA | 23.18% | -43.32% | |||
| EPS Basic | 578.19% | -62.75% | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | 578.19% | -62.75% | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | -6.99% | 4.60% | |||
| Average Diluted Shares Outstanding | -6.99% | 4.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||